Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort

Experience of the National NeuroAIDS Tissue Consortium

Susan Morgello, C. E. Holzer, E. Ryan, C. Young, M. Naseer, S. A. Castellon, A. B. Frol, J. Hampton Atkinson, Benjamin Gelman, I. Grant, E. J. Singer

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) was assessed in a multicentre study. Four sites of the National NeuroAIDS Tissue Consortium performed blinded reratings of audiotaped PRISM interviews of 63 HIV-infected patients. Diagnostic modules for substance-use disorders and major depression were evaluated. Seventy-six per cent of the patient sample displayed one or more substance-use disorder diagnoses and 54% had major depression. Kappa coefficients for lifetime histories of substance abuse or dependence (cocaine, opiates, alcohol, cannabis, sedative, stimulant, hallucinogen) and major depression ranged from 0.66 to 1.00. Overall the PRISM was reliable in assessing both past and current disorders except for current cannabis disorders when patients had concomitant cannabinoid prescriptions for medical therapy. The reliability of substance-induced depression was poor to fair although there was a low prevalence of this diagnosis in our group. We conclude that the PRISM yields reliable diagnoses in a multicentre study of substance-experienced, HIV-infected individuals.

Original languageEnglish (US)
Pages (from-to)131-138
Number of pages8
JournalInternational Journal of Methods in Psychiatric Research
Volume15
Issue number3
DOIs
StatePublished - 2006

Fingerprint

Mental Disorders
Psychiatry
HIV
Substance-Related Disorders
Interviews
Depression
Research
Cannabis
Multicenter Studies
Opiate Alkaloids
Hallucinogens
Cannabinoids
Hypnotics and Sedatives
Cocaine
Prescriptions
Alcohols
Therapeutics

Keywords

  • HIV
  • Interrater reliability
  • PRISM

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort : Experience of the National NeuroAIDS Tissue Consortium. / Morgello, Susan; Holzer, C. E.; Ryan, E.; Young, C.; Naseer, M.; Castellon, S. A.; Frol, A. B.; Atkinson, J. Hampton; Gelman, Benjamin; Grant, I.; Singer, E. J.

In: International Journal of Methods in Psychiatric Research, Vol. 15, No. 3, 2006, p. 131-138.

Research output: Contribution to journalArticle

Morgello, Susan ; Holzer, C. E. ; Ryan, E. ; Young, C. ; Naseer, M. ; Castellon, S. A. ; Frol, A. B. ; Atkinson, J. Hampton ; Gelman, Benjamin ; Grant, I. ; Singer, E. J. / Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort : Experience of the National NeuroAIDS Tissue Consortium. In: International Journal of Methods in Psychiatric Research. 2006 ; Vol. 15, No. 3. pp. 131-138.
@article{b54170fc787047f0be2bf020c08a7a09,
title = "Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort: Experience of the National NeuroAIDS Tissue Consortium",
abstract = "The interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) was assessed in a multicentre study. Four sites of the National NeuroAIDS Tissue Consortium performed blinded reratings of audiotaped PRISM interviews of 63 HIV-infected patients. Diagnostic modules for substance-use disorders and major depression were evaluated. Seventy-six per cent of the patient sample displayed one or more substance-use disorder diagnoses and 54{\%} had major depression. Kappa coefficients for lifetime histories of substance abuse or dependence (cocaine, opiates, alcohol, cannabis, sedative, stimulant, hallucinogen) and major depression ranged from 0.66 to 1.00. Overall the PRISM was reliable in assessing both past and current disorders except for current cannabis disorders when patients had concomitant cannabinoid prescriptions for medical therapy. The reliability of substance-induced depression was poor to fair although there was a low prevalence of this diagnosis in our group. We conclude that the PRISM yields reliable diagnoses in a multicentre study of substance-experienced, HIV-infected individuals.",
keywords = "HIV, Interrater reliability, PRISM",
author = "Susan Morgello and Holzer, {C. E.} and E. Ryan and C. Young and M. Naseer and Castellon, {S. A.} and Frol, {A. B.} and Atkinson, {J. Hampton} and Benjamin Gelman and I. Grant and Singer, {E. J.}",
year = "2006",
doi = "10.1002/mpr.189",
language = "English (US)",
volume = "15",
pages = "131--138",
journal = "International Journal of Methods in Psychiatric Research",
issn = "1049-8931",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders in an HIV-infected cohort

T2 - Experience of the National NeuroAIDS Tissue Consortium

AU - Morgello, Susan

AU - Holzer, C. E.

AU - Ryan, E.

AU - Young, C.

AU - Naseer, M.

AU - Castellon, S. A.

AU - Frol, A. B.

AU - Atkinson, J. Hampton

AU - Gelman, Benjamin

AU - Grant, I.

AU - Singer, E. J.

PY - 2006

Y1 - 2006

N2 - The interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) was assessed in a multicentre study. Four sites of the National NeuroAIDS Tissue Consortium performed blinded reratings of audiotaped PRISM interviews of 63 HIV-infected patients. Diagnostic modules for substance-use disorders and major depression were evaluated. Seventy-six per cent of the patient sample displayed one or more substance-use disorder diagnoses and 54% had major depression. Kappa coefficients for lifetime histories of substance abuse or dependence (cocaine, opiates, alcohol, cannabis, sedative, stimulant, hallucinogen) and major depression ranged from 0.66 to 1.00. Overall the PRISM was reliable in assessing both past and current disorders except for current cannabis disorders when patients had concomitant cannabinoid prescriptions for medical therapy. The reliability of substance-induced depression was poor to fair although there was a low prevalence of this diagnosis in our group. We conclude that the PRISM yields reliable diagnoses in a multicentre study of substance-experienced, HIV-infected individuals.

AB - The interrater reliability of the Psychiatric Research Interview for Substance and Mental Disorders (PRISM) was assessed in a multicentre study. Four sites of the National NeuroAIDS Tissue Consortium performed blinded reratings of audiotaped PRISM interviews of 63 HIV-infected patients. Diagnostic modules for substance-use disorders and major depression were evaluated. Seventy-six per cent of the patient sample displayed one or more substance-use disorder diagnoses and 54% had major depression. Kappa coefficients for lifetime histories of substance abuse or dependence (cocaine, opiates, alcohol, cannabis, sedative, stimulant, hallucinogen) and major depression ranged from 0.66 to 1.00. Overall the PRISM was reliable in assessing both past and current disorders except for current cannabis disorders when patients had concomitant cannabinoid prescriptions for medical therapy. The reliability of substance-induced depression was poor to fair although there was a low prevalence of this diagnosis in our group. We conclude that the PRISM yields reliable diagnoses in a multicentre study of substance-experienced, HIV-infected individuals.

KW - HIV

KW - Interrater reliability

KW - PRISM

UR - http://www.scopus.com/inward/record.url?scp=33750726761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750726761&partnerID=8YFLogxK

U2 - 10.1002/mpr.189

DO - 10.1002/mpr.189

M3 - Article

VL - 15

SP - 131

EP - 138

JO - International Journal of Methods in Psychiatric Research

JF - International Journal of Methods in Psychiatric Research

SN - 1049-8931

IS - 3

ER -